JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, Yen-Wen Liu, MD, PhD, Professor of Medicine, FESC and Yu-Ling Hsu, MD discuss the study design, findings and potential implications for clinical practice and future research questions for the prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.